SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Scrutiny of Jensen Huangs relationship with an alleged Chinese spyand claims of possible chip diversions to Chinais driving concern about Nvidias board investigation, compliance risks, and Huangs tenure. Traders are divided between selling over governance and national-security concerns and buying the dip, arguing the selloff is overblown and Nvidias business remains strong.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers shares sold off after disappointing quarterly results and a reduced profit outlook, with margin pressure and a sequential subscriber decline sharpening concerns about execution. Bulls point to the planned Peptides+ launch, Andrew Hubermans board role and international growth as potential offsets, while skeptics question whether expansion can translate into durable profitability.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTDs quarterly results beat expectations, with stronger guidance and an expanded buyback authorization, but shares gave back much of their initial surge as management acknowledged continued growth challenges. Traders are split between seeing a turnaround and potential short squeeze, and questioning the quality and sustainability of growth amid weaker underlying trends and a cautious earnings call.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,203,846.69715353. The last known price of Ethereum is 2,121.02700944 USD and is down -0.91 over the last 24 hours. It is currently trading on 14303 active market(s) with $13,174,532,202.61 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is drawing attention amid a broad crypto selloff, with traders citing Bitcoins weakness, hot inflation and Fed rate-hike concerns, and leveraged-long liquidations as pressure points. The conversation is largely bearish, though some traders see the decline as a buying opportunity or expect a rebound.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.09792366 USD and is down -1.80 over the last 24 hours. It is currently trading on 1894 active market(s) with $2,759,095,442.76 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to inflation concerns, reduced rate-cut expectations and leveraged liquidations as sources of risk-off pressure. The community is split between fears that the decline will deepen as XRP tests a key round-number support level and dip-buyers citing oversold conditions and reported whale accumulation.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,110,071. The last known price of Bitcoin is 74,895.40905656 USD and is down -0.28 over the last 24 hours. It is currently trading on 12776 active market(s) with $26,892,693,016.04 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Hotter-than-expected U.S. inflation and renewed expectations of Fed rate hikes are weighing on Bitcoin alongside broader risk assets, with traders also pointing to long liquidations. The community is split between bearish calls for further declines and dip buyers arguing the selloff is overdone and support may hold.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine shares plunged after its quarterly report beat revenue expectations and raised its sales outlook, but gross-margin pressure and unchanged EBITDA guidance raised concerns about whether growth is translating into profit. Traders are split between calling the selloff an overreaction and pointing to margin compression, debt costs, and dilution risks as reasons for caution.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs Nov. 22 decision on Capricors deramiocel for Duchenne muscular dystrophy, with the current application focused on preserving upper-limb function. Many traders are optimistic, citing the HOPE-3 data, physician support and an American Heart Association award for cardiac findings, while others stress that approval is uncertain given the FDA advisory panels negative vote on the cardiac indication and concerns about the evidence.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two is drawing attention around the upcoming GTA VI launch, with managements description of preorders as far above expectations fueling optimism alongside its earnings update. Traders are debating whether that demand is already priced in and whether unchanged bookings guidance and weaker recurring spending could leave the stock vulnerable to a sell-the-news reaction.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics quarterly results showed sharply higher revenue and a third increase to its full-year outlook, with traders crediting growing demand for the Eversense 365 CGM. Bulls welcome the rally and commercial progress, while skeptics point to ongoing losses, cash burn, dilution risk, and concerns about management execution.

statis crypto Watchlist

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RKLB Stock Sinks After-Hours On Q3 Earnings Miss, But Neutron Launches Now Fetch $70M – And New Buyers Face A 2030s Wait

Rocket Labs quarterly results are driving debate: revenue and backlog growth drew praise, while an earnings miss and Neutrons launch delay to 2027 weighed on sentiment. Bulls view the selloff as a buying opportunity, while bears focus on execution risks and the lack of a firm launch timeline.

The decline appears tied to Rocket Labs Q3 results: its $0.12-per-share loss was wider than the expected $0.07 loss, despite revenue and backlog growth. Neutrons first launch is now no earlier than 2027, and management gave no specific launch date.

RKLB Stock Draws Wall Street’s Attention – Cantor Sees Attractive Entry Point Ahead Of These Two Key Events

Equity

Cantor Fitzgerald highlighted Rocket Lab’s successful launch record, diversified rocket portfolio, growing customer base and dedicated launch facilities as competitive advantages.

IonQ Shares Fall With Space Stocks: What's Going On?

IonQ is trading lower Tuesday along with space stocks, including Rocket Lab and AST SpaceMobile, which fell after reporting Q3 results.read more...

MDA SPACE AND GLOBALSTAR COMPLETE INITIAL ON-ORBIT FUNCTIONAL TESTS FOR GLOBALSTAR 2-R MISSION

MDA SPACE AND GLOBALSTAR COMPLETE INITIAL ON-ORBIT FUNCTIONAL TESTS FOR GLOBALSTAR 2-R MISSION MDA SPACE AND GLOBALSTAR COMPLETE INITIAL ON-ORBIT FUNCTIONAL TESTS FOR GLOBALSTAR 2-R MISSIONPR NewswireTORONTO, Nov. 10, 2026 First set of eight satellites launched on August 15 have passed initial...

Rocket Lab Shares Lose Altitude Tuesday: What's Going On?

Rocket Lab shares are trading lower Tuesday after the company reported mixed third-quarter financial results late Monday.read more...

US Stock Futures Mixed As Investors Await CPI Data — AMD, CRWV, RKLB Stocks In Focus

Oil prices continued to decline as easing concerns about a potential U.S. military strike on Iran reduced fears of supply disruptions.

Rocket Lab CEO Peter Beck Says 'Critical Minerals' Remain 'a Challenge for a Number of Industries' While Trump Pushes Greenland Exploration

Rocket Lab controls much of its supply chain, but CEO Peter Beck says critical minerals remain a challenge for many industries.read more...

RKLB Stock Tumbles Over 8% Overnight as Neutron Delays Overshadow Record Revenue  but Analyst Sees Rocket Lab's Solar, Connectivity Advantage

Rocket Lab CEO Peter Beck backs defense-focused orbital data centers, citing secure communications, Neutron rocket's $515M deal.read more...

RKLB Stock Sinks After-Hours On Q3 Earnings Miss, But Neutron Launches Now Fetch $70M – And New Buyers Face A 2030s Wait 

Longer term, Rocket Lab wants half of Neutron’s capacity for its own services and sees potential Neutron non-GAAP gross margins above 50%.

Rocket Lab USA Q3 2026 Earnings Call Transcript

Rocket Lab USA (NASDAQ:RKLB) reported third-quarter financial results on Monday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs.read more...

Rocket Lab Q3 Loss Widens

(RTTNews) - Rocket Lab Corporation (RKLB), a provider of launch services and space systems, on Monday reported a wider loss for the third as higher costs offset revenue growth across its launch and space systems businesses...

$RKLB Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.12 down -300.00% YoY
• Reported revenue of $267.83M up 72.70% YoY
• Rocket Lab expects Q4 2026 revenue between $270M and $290M, GAAP gross margins between 34% and 36%, and an Adjusted EBITDA loss between $14M and $20M.

Stocktwits

Rocket Lab USA Inc

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.12 down -300.00% YoY
• Reported revenue of $267.83M up 72.70% YoY
• Rocket Lab expects Q4 2026 revenue between $270M and $290M, GAAP gross margins between 34% and 36%, and an Adjusted EBITDA loss between $14M and $20M.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Extremely Bullish Sentiment

<ul class="summary-bullets"><li>Cantor lowered Rocket Lab’s price target to $111 from $122, but the updated price target still represents around a 110% upside potential from current levels.</li><li>Clear Street analyst Greg Pendy said the company’s record backlog provides ‘multi-year visibility.’</li><li>Rocket Lab’s spacecraft for NASA’s Escapade mission successfully completed Trans-Mars injection burns, putting it on course for Mars.</li></ul>Rocket Lab (<a class="mention" data-mention="$RKLB" data-symbol-id="RKLB" href="https://stocktwits.com/symbol/RKLB" target="_blank">RKLB</a>) was on investors’ radar on Tuesday after reporting its third-quarter results, with Cantor Fitzgerald highlighting multiple factors that support a bullish outlook and an attractive entry point.Cantor lowered its price target on the stock to $111 from $122, but maintained an 'Overweight' rating, according to The Fly. The updated price target still represents around a 110% upside potential from current levels.Rocket Lab <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.rocketlabcorp.com/news-releases/news-release-details/rocket-lab-announces-third-quarter-2026-financial-results-posts">reported</a> a 73% increase in third-quarter (Q3) revenue to $267.83 million, beating the $257.18 million consensus estimate, as per Fiscal.ai. However, its loss of $0.12 per share exceeded expectations of a $0.07-per-share loss. Rocket Lab expects fourth-quarter (Q4) revenue of $270 million to $290 million.<h2 class="st-heading-2">Neutron Commercialization, Iridium Acquisition In Focus</h2>The firm highlighted Rocket Lab’s successful launch record, diversified rocket portfolio, growing customer base, and dedicated launch facilities as competitive advantages, providing an attractive entry point ahead of Neutron's commercialization and the closing of the Iridium acquisition.Meanwhile, Clear Street raised RKLB’s price target to $110 from $105 and kept a ‘Buy’ rating, with analyst Greg Pendy adding that the company’s record backlog provides “multi-year visibility.” However, Piper Sandler said Neutron’s launch timeline remains the most important near-term factor despite growing launch demand.<h2 class="st-heading-2">Neutron Contracts Drive Backlog</h2>Last month, Rocket Lab said that the much-anticipated launch of its Neutron rocket has been postponed to 2027, following manufacturing issues with its first-stage fuel tank dome. The company had previously planned a Q4 launch.Despite the delay, the company secured over $515 million in Neutron contracts during Q3, bringing its total backlog to $3.57 billion.Rocket Lab is also set to acquire Iridium Communications for about $8 billion to provide global satellite communication services. The deal is expected to close by mid-2027, subject to regulatory approvals.<h2 class="st-heading-2">RKLB’s Mars Mission Spacecraft Completes Key Engine Burns</h2>Separately, Rocket Lab <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/11/10/3399441/0/en/twin-satellites-built-by-rocket-lab-for-nasa-s-escapade-mission-complete-successful-trans-mars-injection-burns-setting-course-for-the-red-planet.html">announced</a> on Tuesday that two spacecraft it built for NASA’s ESCAPADE mission successfully completed Trans-Mars injection (TMI) burns, critical engine burns that put them on course for the red planet.The twin satellites, Blue and Gold, will study how the solar wind affects Mars’ atmosphere. Both spacecraft are expected to enter Mars orbit in September 2027, with scientific operations beginning in 2028.<h2 class="st-heading-2">Retail Turns ‘Bullish’ On RKLB</h2>Despite the slump, retail sentiment surrounding RKLB on Stocktwits turned ‘bullish’ from ‘neutral’ over the past 24 hours, amid ‘high’ message volume.<img src="https://news.stocktwits-cdn.com/RKLB_f3a810a91c.png" alt="RKLB.png">One user called the Neutron launch delay “just a bump in the road.”<stembedurl>https://stocktwits.com/KobiZholtack/message/668653884</stembedurl>The stock is down nearly 23% so far in 2026.Also read: <a href="https://stocktwits.com/news-articles/markets/equity/venture-global-ceo-eyes-new-growth-opportunity-off-grid-power-raises-fy2026-guidance-record-q3-earnings/cNGuSNYR9JG">Venture Global CEO Eyes New Growth Opportunity In Off-Grid Power For AI Data Centers – Firm Raises FY2026 Guidance After Record Q3 Earnings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Rocket Lab USA, Inc. is displayed on a smartphone screen on May 06, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Tema Space Innovators ETF

Rocket Lab (RKLB) stock price today, news, financials, community insights, and trading ideas, Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

RKLB - Rocket Lab Stock Price Today, News, Analysis and Trading Ideas

SpaceX is one of the most anticipated IPOs in recent history. Its booming business across the space industry has created tremendous hype, but hype doesn't always translate to outperformance. Do you think SpaceX will outperform the S&P 500 over the next five years?

Do you think SpaceX ($SPCX) will outperform the S&amp;P 500 ($SPY) over the next 5 years?

SpaceX

Stocktwits Polls

Investors are weighing the impact of shifted launch timelines for the Neutron rocket against long-term development progress.

A sharp disconnect between strong revenue growth and an EPS miss linked to debt-extinguishment costs has fueled volatility.

Optimists point to a massive $3.57 billion backlog and lucrative Pentagon contracts as evidence of long-term business strength.

Battles are intensifying between bearish traders focused on earnings targets and bulls anticipating a rapid rebound from dip buyers.

Current Price	$59.18
Prev Close	$58.86
Open	$54.99
Dividend Yield	0.00%
50-Day Moving Average	$62.45
Beta	2.54
Avg. Volume	20.11M
PE Ratio	-210.52

52-Week High	$151.00
52-Week Low	$37.57
Market Capitalization	$35.23B
EPS (Annual)	-$0.3735
Price to Book	10.08
Revenue Per Employee	$231,461.15

Feed

News

Sentiment

Earnings

Fundamentals

Info

RKLB Fundamentals